Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Inequities in timely treatment (Tx) initiation for patients (pts) with acute myeloid leukemia (AML) treated in a predominantly community setting in the United States (US).

View Full Paper
Ask AI
Bookmark
Share

Authors

EMEsprit MaAEAnn‐Kathrin EisfeldOOOlatoyosi Odenike

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ma et al. (2024) studied this question.

synapsesocial.com/papers/68e67054b6db6435875fa873https://doi.org/10.1200/jco.2024.42.16_suppl.1574
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rethinking disparity in Acute Myeloid Leukemia, a new perspective in the Asian population2025
  2. 2Racial disparities in genomic alterations and survival outcomes in Acute Myeloid Leukemia (AML)2025
  3. 3National analysis of real-world racial and ethnic disparities in mortality, complications, and healthcare costs among adults hospitalized with newly diagnosed Acute Myeloid Leukemia2025
  4. 4Abstract 5429: REAL-AML: Real-world predictors of early mortality and treatment inequities in acute myeloid leukemia across a multi-institutional U.S. cohort.2026
  5. 5Treatment (Tx) inequities in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) harboring actionable driver oncogenes (ADO) in the first-line (1L) setting.2024